American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors

Debbie Saslow, Philip E. Castle, J. Thomas Cox, Diane D. Davey, Mark H. Einstein, Daron G. Ferris, Sue J. Goldie, Diane M. Harper, Walter Kinney, Anna Barbara Moscicki, Kenneth L. Noller, Cosette M. Wheeler, Terri Ades, Kimberly S. Andrews, Mary K. Doroshenk, Kelly Green Kahn, Christy Schmidt, Omar Shafey, Robert A. Smith, Edward E. PartridgeFrancisco Garcia

Research output: Contribution to journalReview article

403 Scopus citations

Abstract

The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.

Original languageEnglish (US)
Pages (from-to)7-28
Number of pages22
JournalCa-A Cancer Journal for Clinicians
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., Harper, D. M., Kinney, W., Moscicki, A. B., Noller, K. L., Wheeler, C. M., Ades, T., Andrews, K. S., Doroshenk, M. K., Kahn, K. G., Schmidt, C., Shafey, O., Smith, R. A., ... Garcia, F. (2007). American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. Ca-A Cancer Journal for Clinicians, 57(1), 7-28. https://doi.org/10.3322/canjclin.57.1.7